Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Barricaid (United States)
InstitutionResearch output, impact & collaborations
Barricaid (United States) is a research organisation in Woburn, US. OpenAlex records 60 works and 2,250 citations for it. 42 researchers list it as their most recent affiliation.
60
Works
2,250
Citations
42
Researchers
52
Avg h-index
How has Barricaid (United States)'s publication output changed over time?
ScholarIQpublication output · 2011–2022
Output grew0% over the shown period — from 1 works in 2011 to 1 in 2022.
1
1
1
1
1
1
201120142017201820212022
What are the most-cited papers on Barricaid (United States)?
ScholarIQmost cited works
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan Jagasia, Hildegard Greinix, Mukta Arora, Kirsten M. Williams, Daniel Wolff, Edward W. Cowen, Jeanne Palmer, Daniel J. Weisdorf, Nathaniel S. Treister, Guang‐Shing Cheng, Holly Kerr, Pamela Stratton, Rafael F. Duarte, George B. McDonald, Yoshihiro Inamoto, Afonso Celso Vigorito, Sally Arai, Manuel B. Datiles, David A. Jacobsohn, Theo Heller, Carrie L. Kitko, Sandra A. Mitchell, Paul J. Martin, Howard M. Shulman, Roy S. Wu, Corey Cutler, Georgia B. Vogelsang, Stephanie J. Lee, Steven Z. Pavletic, Mary E.D. Flowers
S59987174. 20145,435 CitationsOPEN ACCESS
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
Madan Jagasia, Mukta Arora, Mary E.D. Flowers, Nelson J. Chao, Philip L. McCarthy, Corey Cutler, Álvaro Urbano-Ispizúa, Steven Z. Pavletic, Michael Haagenson, Mei-Jie Zhang, Joseph H. Antin, Brian J. Bolwell, Christopher Bredeson, Jean‐Yves Cahn, Mitchell S. Cairo, Robert Peter Gale, Vikas Gupta, Stephanie J. Lee, Mark R. Litzow, Daniel J. Weisdorf, Mary M. Horowitz, Theresa Hahn
Blood. 2011703 Citations
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
David B. Miklos, Corey Cutler, Mukta Arora, Edmund K. Waller, Madan Jagasia, Iskra Pusic, Mary E.D. Flowers, Aaron C. Logan, Ryotaro Nakamura, Bruce R. Blazar, Yunfeng Li, Stephen Chang, Indu Lal, Jason A. Dubovsky, Danelle F. James, Lori Styles, Samantha Jaglowski
Blood. 2017505 CitationsOPEN ACCESS
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aleksandr Lazaryan, Aravind Ramakrishnan, Zachariah DeFilipp, Amandeep Salhotra, Wanxing Chai‐Ho, Rohtesh S. Mehta, Trent Wang, Mukta Arora, Iskra Pusic, Ayman Saad, Nirav N. Shah, Sunil Abhyankar, Carlos Bachier, John P. Galvin, Annie Im, Amelia Langston, Jane L. Liesveld, Mark Juckett, Aaron C. Logan, Levanto Schachter, Asif Alavi, Dianna S. Howard, Harlan W. Waksal, John L. Ryan, David Eiznhamer, Sanjay Aggarwal, Jonathan Ieyoub, Olivier Schueller, Laurie Green, Zhongming Yang, Heidi Krenz, Madan Jagasia, Bruce R. Blazar, Steven Z. Pavletic
Blood. 2021338 CitationsOPEN ACCESS
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study
Jason Chesney, Karl D. Lewis, Harriet M. Kluger, Omid Hamid, Eric D. Whitman, Sajeve Thomas, Martin Wermke, Mike Cusnir, Evidio Domingo‐Musibay, Giao Q. Phan, John M. Kirkwood, Jessica C. Hassel, Marlana Orloff, James Larkin, Jeffrey S. Weber, Andrew J.S. Furness, Nikhil I. Khushalani, Theresa Medina, Michael E. Egger, Friedrich Graf Finckenstein, Madan Jagasia, Parameswaran Hari, Giri Sulur, Wen Shi, Xiao Wu, Amod A. Sarnaik
S2754803477. 2022334 CitationsOPEN ACCESS
How much of the research on Barricaid (United States) is open access?
ScholarIQopen access share
83%OPEN ACCESS
Gold
17%
Green
0%
Hybrid
17%
Bronze
50%
Closed
17%